Log in

NASDAQ:NXTCNextCure Stock Price, Forecast & News

$9.70
+0.20 (+2.11 %)
(As of 08/5/2020 04:00 PM ET)
Add
Compare
Today's Range
$9.40
Now: $9.70
$9.98
50-Day Range
$8.15
MA: $15.96
$25.04
52-Week Range
$8.00
Now: $9.70
$109.00
Volume810,199 shs
Average Volume1.64 million shs
Market Capitalization$266.94 million
P/E RatioN/A
Dividend YieldN/A
Beta-0.58
There is no company description available for NextCure Inc.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 4.2Community Rank: 2.8Dividend Strength: 0.0Insider Behavior: 1.0Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.73 out of 5 stars


Industry, Sector and Symbol

Industry Pharmaceutical preparations
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:NXTC
CUSIPN/A
CIKN/A
Phone240-399-4900

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$6.35 million
Book Value$14.13 per share

Profitability

Net Income$-33,740,000.00

Miscellaneous

EmployeesN/A
Market Cap$266.94 million
Next Earnings Date8/10/2020 (Estimated)
OptionableNot Optionable
$9.70
+0.20 (+2.11 %)
(As of 08/5/2020 04:00 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive NXTC News and Ratings via Email

Sign-up to receive the latest news and ratings for NXTC and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











NextCure (NASDAQ:NXTC) Frequently Asked Questions

How has NextCure's stock been impacted by COVID-19 (Coronavirus)?

NextCure's stock was trading at $38.22 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, NXTC shares have decreased by 74.6% and is now trading at $9.70.
View which stocks have been most impacted by Coronavirus
.

Do Wall Street analysts recommend investors buy shares of NextCure?

9 Wall Street analysts have issued "buy," "hold," and "sell" ratings for NextCure in the last year. There are currently 5 hold ratings and 4 buy ratings for the stock, resulting in a consensus recommendation of "Hold."
View analyst ratings for NextCure
.

When is NextCure's next earnings date?

NextCure is scheduled to release its next quarterly earnings announcement on Monday, August 10th 2020.
View our earnings forecast for NextCure
.

How were NextCure's earnings last quarter?

NextCure Inc (NASDAQ:NXTC) posted its quarterly earnings data on Thursday, May, 7th. The company reported $0.33 earnings per share for the quarter, beating analysts' consensus estimates of ($0.44) by $0.77. The business earned $22.38 million during the quarter, compared to analyst estimates of $1.30 million. NextCure had a negative net margin of 65.22% and a negative return on equity of 7.12%.
View NextCure's earnings history
.

What price target have analysts set for NXTC?

9 brokers have issued 1 year price objectives for NextCure's shares. Their forecasts range from $11.00 to $87.00. On average, they expect NextCure's stock price to reach $32.70 in the next twelve months. This suggests a possible upside of 237.1% from the stock's current price.
View analysts' price targets for NextCure
.

Has NextCure been receiving favorable news coverage?

News headlines about NXTC stock have been trending negative on Thursday, according to InfoTrie. The research group identifies positive and negative news coverage by monitoring more than six thousand news and blog sources. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. NextCure earned a news impact score of -2.0 on InfoTrie's scale. They also gave news headlines about the company a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an impact on the stock's share price in the next few days.
View the latest news about NextCure
.

Who are some of NextCure's key competitors?

What other stocks do shareholders of NextCure own?

Based on aggregate information from My MarketBeat watchlists, some companies that other NextCure investors own include Amgen (AMGN), Alibaba Group (BABA), CVS Health (CVS), Dicerna Pharmaceuticals (DRNA), UnitedHealth Group (UNH), Honeywell International (HON), Johnson & Johnson (JNJ), NVIDIA (NVDA), AT&T (T) and Arena Pharmaceuticals (ARNA).

When did NextCure IPO?

(NXTC) raised $75 million in an initial public offering (IPO) on Thursday, May 9th 2019. The company issued 5,000,000 shares at a price of $14.00-$16.00 per share. Morgan Stanley, BofAMerrill Lynch, Pierce and Piper Jaffray served as the underwriters for the IPO.

What is NextCure's stock symbol?

NextCure trades on the NASDAQ under the ticker symbol "NXTC."

Who are NextCure's major shareholders?

NextCure's stock is owned by many different retail and institutional investors. Top institutional shareholders include Matthews International Capital Management LLC (0.92%), Vident Investment Advisory LLC (0.20%), Vident Investment Advisory LLC (0.20%), Asymmetry Capital Management L.P. (0.18%), SG Americas Securities LLC (0.12%) and Swiss National Bank (0.10%). Company insiders that own NextCure stock include Sofinnova Venture Partners Ix,, Stella Xu and X LP Canaan.
View institutional ownership trends for NextCure
.

Which institutional investors are buying NextCure stock?

NXTC stock was purchased by a variety of institutional investors in the last quarter, including Matthews International Capital Management LLC, Asymmetry Capital Management L.P., SG Americas Securities LLC, Swiss National Bank, Vident Investment Advisory LLC, Vident Investment Advisory LLC, Bessemer Group Inc., and Virtus ETF Advisers LLC. Company insiders that have bought NextCure stock in the last two years include Sofinnova Venture Partners Ix,, Stella Xu, and X LP Canaan.
View insider buying and selling activity for NextCure
.

How do I buy shares of NextCure?

Shares of NXTC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is NextCure's stock price today?

One share of NXTC stock can currently be purchased for approximately $9.70.

How big of a company is NextCure?

NextCure has a market capitalization of $266.94 million and generates $6.35 million in revenue each year. The company earns $-33,740,000.00 in net income (profit) each year or ($2.15) on an earnings per share basis.

What is NextCure's official website?

The official website for NextCure is www.nextcure.com.

How can I contact NextCure?

NextCure's mailing address is 9000 VIRGINIA MANOR ROAD SUITE 200, BELTSVILLE MD, 20705. The company can be reached via phone at 240-399-4900 or via email at [email protected]

This page was last updated on 8/6/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.